Cargando…

Flunarizine is more effective than topiramate in patients with chronic migraine and medication overuse headache

Detalles Bibliográficos
Autores principales:	Gracia-Naya, M, Hernando-Quintana, N, García-Gomara, MJ, Sánchez-Valiente, S, Ríos, C, Santos-Lasaosa, S, Mauri, JA, Artal-Roy, J, Latorre-Jimenez, AM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620084/ http://dx.doi.org/10.1186/1129-2377-1-S14-P202

Ejemplares similares

Outcomes of topiramate for prophylaxis of chronic migraine headache
por: Ahmed, Khawar, et al.
Publicado: (2022)

Managing Migraine: Medication Overuse Headache and Treatment with Eptinezumab
por: Limberg, Nicole
Publicado: (2023)

A comparative study of magnesium, flunarizine and amitriptyline in the prophylaxis of migraine
por: Demirkaya, Seref, et al.
Publicado: (2000)

The Efficacy of Venlafaxine, Flunarizine, and Valproic Acid in the Prophylaxis of Vestibular Migraine
por: Liu, Fenye, et al.
Publicado: (2017)

Chronic migraine plus medication overuse headache: two entities or not?
por: Negro, Andrea, et al.
Publicado: (2011)

Withdrawal failure in patients with chronic migraine and medication overuse headache
por: D’Amico, Domenico, et al.
Publicado: (2021)

Medication Overuse Headaches among Children—The Contribution of Migraine and TTH
por: Genizi, Jacob, et al.
Publicado: (2023)

Topiramate in migraine progression
por: Ruiz, Luigi, et al.
Publicado: (2009)

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine
por: Deligianni, Christina I., et al.
Publicado: (2023)

Inhibition of gap junctional intercellular communication by an anti-migraine agent, flunarizine
por: Yeo, Joo Hye, et al.
Publicado: (2019)

Patient Experience of Flunarizine for Vestibular Migraine: Single Centre Observational Study
por: Rashid, Sk Mamun Ur, et al.
Publicado: (2022)

Temperament and character profiles of patients with chronic migraine and medication-overuse headache
por: Watanabe, Y, et al.
Publicado: (2013)

Migraine-specific quality of life questionnaire and relapse of medication overuse headache
por: Caproni, Stefano, et al.
Publicado: (2015)

Risk of medication overuse headache across classes of treatments for acute migraine
por: Thorlund, Kristian, et al.
Publicado: (2016)

Effects of smartphone overuse on headache, sleep and quality of life in migraine patients
por: Demir, Yasemin P., et al.
Publicado: (2019)

Chronic migraine prevention with topiramate
por: Peres, M. F. P., et al.
Publicado: (2006)

Outcome of topiramate in migraine prophylaxis
por: Ibrahim, Etedal Ahmed A., et al.
Publicado: (2023)

Flunarizine Induced Parkinsonism in Migraine Group: A Nationwide Population-Based Study
por: Lin, Wei, et al.
Publicado: (2019)

Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication‐overuse headache
por: Marmura, Michael J., et al.
Publicado: (2021)

Theory of Mind in migraine and medication-overuse headache: A cross-sectional study
por: Romozzi, Marina, et al.
Publicado: (2022)

Distinct Food Triggers for Migraine, Medication Overuse Headache and Irritable Bowel Syndrome
por: Ceren Akgor, Merve, et al.
Publicado: (2023)

P060. Vitamin D deficiency in episodic migraine, chronic migraine and medication-overuse headache patients
por: Iannacchero, Rosario, et al.
Publicado: (2015)

Effect of Flunarizine on Serum Glutamate Levels and its Correlation with Headache Intensity in Chronic Tension-Type Headache Patients
por: Surbakti, Khairul Putra, et al.
Publicado: (2017)

EHMTI-0146. Topiramate in migraine prevention
por: Ristic, S, et al.
Publicado: (2014)

Advances in topiramate as prophylactic treatment for migraine
por: Hu, Chuan, et al.
Publicado: (2021)

FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine
por: Rothrock, John F., et al.
Publicado: (2019)

Monoclonal antibodies for chronic migraine and medication overuse headache: A real-world study
por: Krymchantowski, Abouch V., et al.
Publicado: (2023)

Prophylatic treatment of migraine and migraine clinical variants with topiramate: an update
por: Carmona, Sergio, et al.
Publicado: (2009)

Medication-overuse headache: an update
por: Sarchielli, Paola
Publicado: (2015)

Clinical effect of flunarizine combined with duloxetine in the treatment of chronic migraine comorbidity of depression and anxiety disorder
por: Zhu, Junliang, et al.
Publicado: (2022)

Topiramate in the prevention of pediatric migraine: literature review
por: Ferraro, Diana, et al.
Publicado: (2008)

Effective dose of topiramate in pediatric migraine prophylaxis
por: Abbaskhanian, Ali, et al.
Publicado: (2012)

Meta-analysis of efficacy of topiramate in migraine prophylaxis★
por: Guo, Yiyi, et al.
Publicado: (2012)

The Efficacy and Safety of Topiramate for Prophylaxis of Migraine in Children
por: FALLAH, Razieh, et al.
Publicado: (2013)

Prophylaxis of Childhood Migraine: Topiramate Versus Propranolol
por: TONEKABONI, Seyed Hassan, et al.
Publicado: (2013)

The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine
por: Martelletti, Paolo
Publicado: (2018)

The evolving classifications and epidemiological challenges surrounding chronic migraine and medication overuse headache: a review
por: Schembri, Emanuel, et al.
Publicado: (2022)

European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
por: Raffaelli, Bianca, et al.
Publicado: (2023)

Association between suicidal risks and medication-overuse headache in chronic migraine: a cross-sectional study
por: Wang, Yen-Feng, et al.
Publicado: (2021)

Medication–overuse headache: pathophysiological insights
por: Calabresi, P., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_eb9j004cc084knl2u4hda3ftr1